Genetic mutations and mechanisms in dilated cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Cardiomyopathies are a major cause of heart failure, often driven by genetic mutations.
• Hypertrophic cardiomyopathy (HCM) is characterized by thickened heart muscle, primarily linked to sarcomere gene mutations like MYH7 and MYBPC3.
• Dilated cardiomyopathy (DCM) presents genetic heterogeneity, involving diverse genes and resulting in enlarged ventricles and impaired function.

Purpose of the Study:

• To review the genetic underpinnings of inherited cardiomyopathies, focusing on hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
• To highlight the distinct genetic mutation patterns in HCM versus DCM.
• To emphasize the growing role of genetic testing in diagnosing and managing inherited cardiomyopathies.

Main Methods:

• Review of existing literature on genetic mutations in HCM and DCM.
• Analysis of mutation prevalence and genetic heterogeneity in both conditions.
• Discussion of clinical implications and diagnostic approaches, including genetic testing.

Main Results:

• HCM is largely explained by mutations in sarcomere protein genes (MYH7, MYBPC3), often private.
• DCM exhibits greater genetic diversity, with over 50 linked genes affecting various cellular components.
• Private mutations are common in both HCM and DCM, with few recurring mutation hotspots.

Conclusions:

• Genetic mutations are central to inherited cardiomyopathies, with distinct patterns in HCM and DCM.
• Genetic testing is increasingly crucial for identifying at-risk individuals and guiding management of inherited DCM.
• Understanding the genetic basis of cardiomyopathies aids in risk stratification and personalized medicine approaches.